Creative Planning Abb Vie Inc. Put Options Transaction History

Creative Planning

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $1.23 Million - $1.4 Million	7,700 New	7,700 $1.4 Million
Q3 2023 Nov 16, 2023	BUY	$133.59 - $154.65 $1.03 Million - $1.19 Million	7,700 New	7,700 $1.15 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $145,178 - $180,125	1,100 Added 110.0%	2,100 $1,000
Q2 2018 Jul 20, 2018	SELL	$89.78 - $106.23 $808,020 - $956,070	-9,000 Reduced 90.0%	1,000 $0
Q1 2018 Apr 18, 2018	BUY	$92.01 - $123.21 $920,100 - $1.23 Million	10,000 New	10,000 $167,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.